CA Patent

CA2627358C — Heterocyclic modulators of atp-binding cassette transporters

Assigned to Vertex Pharmaceuticals Inc · Expires 2015-10-06 · 11y expired

What this patent protects

Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"). In one bro…

USPTO Abstract

Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"). In one broad aspect, there is disclosed a compound of the general formula (I): (see formula I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R'3, R4, and n are described herein. In a more specific embodiment, the invention relates to a compound having the following formula: (see formula II).

Drugs covered by this patent

Patent Metadata

Patent number
CA2627358C
Jurisdiction
CA
Classification
—
Expires
2015-10-06
Drug substance claim
No
Drug product claim
No
Assignee
Vertex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.